SciELO - Scientific Electronic Library Online

 
vol.53 número3Farmacoterapia actual de la amibiasis, avances en nuevas drogas y diseño de una vacuna índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Investigación Clínica

versión impresa ISSN 0535-5133

Resumen

PEREZ-AGUILAR, Mary Carmen; GONCALVES, Loredana  y  BONFANTE-CABARCAS, Rafael. Adenosine deaminase in severe combined immunodeficiency syndrome. Invest. clín [online]. 2012, vol.53, n.3, pp.315-324. ISSN 0535-5133.

Adenosine deaminase is an enzyme of the purine metabolism whose function is to convert adenosine to inosine and deoxyadenosine to deoxyinosine. The ecto-ADA1 binding to the cell surface through CD26 contributes to the regulation of cytokines and stimulates the proliferation of T cells by activating CD45. The deficiency of this enzyme generates the severe combined immunodeficiency syndrome, characterized by the accumulation of deoxyadenosine and adenine metabolites, which have toxic effects on lymphocytes, affecting DNA synthesis and consequently, clonal expansion. Early diagnosis of this immunodeficiency is essential, as it significantly reduces morbidity and mortality associated with recurrent infections. Recent advances in molecular biology and genetics have led to the identification of genetic defects of many primary immunodeficiencies and the development of promising diagnostic tools and treatment

Palabras clave : adenosine; adenosine deaminase; immune system; severe combined immunodeficiency.

        · resumen en Español     · texto en Español     · Español ( pdf )